Interim results (2-year) of a French non-interventional study to assess the long-term safety and efficacy of BeneFIX

被引：0
|
作者：
Rothschild, C. [1 ]
Trossaert, M. [2 ]
Claeyssens, S. [3 ]
Lambert, T. [4 ]
Hassoun, A. [5 ]
Volot, F. [6 ]
Dubanchet, A. [7 ]
机构：
[1] Necker AP HP Hosp, Hemophilia Treatment Ctr, Paris, France
[2] Hop Hotel Dieu, Hemophilia Treatment Ctr, Nantes, France
[3] Purpan Hosp, Hemophilia Treatment Ctr, Toulouse, France
[4] Bicetre AP HP Hosp, Hemophilia Treatment Ctr, Le Kremlin Bicetre, France
[5] Simone Veil Hosp, Hemophilia Treatment Ctr, Montmorency Foret, France
[6] Bocage Hosp, Hemophilia Treatment Ctr, Dijon, France
[7] Pfizer, Paris, France
来源：
HAEMOPHILIA | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：23 / 24
页数：2
相关论文
共 50 条
  • [41] Patients switching to fingolimod in daily clinical routine: 2 year interim results from the non-interventional study PANGAEA 2.0
    Schulze-Topphoff, U.
    Ettle, B.
    Cornelissen, C.
    Ziemssen, T.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 932 - 932
  • [42] First interim results of IDELA PASS: a prospective non-interventional post authorization safety study of idelalisib in Germany
    Abenhardt, W.
    Knauf, W.
    Eissmann, P.
    Hucke, N.
    van Troostenburg, A.
    Watzke, S.
    Hoechstetter, M.
    Rummel, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 139 - +
  • [43] Long-term efficacy and safety of oral almotriptan: Interim analysis of a 1-year open study
    Cabarrocas, X
    Esbri, R
    Peris, F
    Ferrer, P
    HEADACHE, 2001, 41 (01): : 57 - 62
  • [44] 2-year safety and efficacy results for benralizumab
    Chung, Kian Fan
    LANCET RESPIRATORY MEDICINE, 2019, 7 (01): : 5 - 6
  • [45] Long-Term Efficacy and Safety of Fremanezumab in Migraine: Results of a 1-Year Study
    Goadsby, P. J.
    Monteith, T.
    Cohen, J. M.
    Yang, R.
    HEADACHE, 2019, 59 : 99 - 99
  • [46] Long-Term Efficacy and Safety of Fremanezumab in Migraine: Results of a 1-Year Study
    Goadsby, Peter
    Monteith, Teshamae
    Yeung, Paul P.
    Cohen, Joshua
    Yang, Ronghua
    NEUROLOGY, 2019, 92 (15)
  • [47] Assessment of Immunoglobulins in a Long-Term Non-Interventional Study (SIGNS Study). Rationale, Design, and Methods
    Kirch, Wilhelm
    Gold, Ralf
    Hensel, Manfred
    Fasshauer, Maria
    Pittrow, David
    Huscher, Doerte
    Reiser, Marcel
    Stangel, Martin
    Baumann, Ulrich
    Borte, Michael
    MEDIZINISCHE KLINIK, 2010, 105 (09) : 647 - 651
  • [48] Long-Term (2-Year) Safety and Efficacy of Adjunctive ZX008 (Fenfluramine Hydrochloride Oral Solution) for Dravet Syndrome: Interim Results of an Ongoing Open-Label Extension Study
    Sullivan, Joseph
    Auvin, Stephane
    Pringsheim, Milka
    Knupp, Kelly
    Wirrell, Elaine
    Farfel, Gail
    Galer, Bradley
    Morrison, Glenn
    Lock, Michael
    Gammaitoni, Arnold
    Thiele, Elizabeth
    NEUROLOGY, 2020, 94 (15)
  • [49] Long-term efficacy and safety of adalimumab in the treatment of active ankylosing spondylitis: Results of an open-label, 2-year trial
    Haibel, H.
    Brandt, H. C.
    Baraliakos, X.
    Rudwaleit, M.
    Listing, J.
    Braun, J.
    Kupper, H.
    Sieper, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 218 - 219
  • [50] Deucravacitinib Long-term Efficacy and Safety in Plaque Psoriasis: 2-Year Results from the Phase 3 POETYK PSO Program
    Warren, Richard
    Sofen, Howard
    Imafuku, Shinichi
    Szepietowski, Jacek C.
    Blauvelt, Andrew
    Spelman, Lynda
    Toms, Jessica
    Buck, Alex
    Banerjee, Subhashis
    Menter, Alan
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4230 - 4232
12345